|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 617.70 CNY | +0.93% |
|
+7.30% | +22.61% |
| 19/12 | QuantumCTek Chair Dies | MT |
| 18/12 | Quantum CTEK's chairman dies | RE |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
Profitability | |||||||||
Return on Assets | -1.91 | -3.47 | -4.63 | -5.11 | -1.55 | ||||
Return on Total Capital | -2.26 | -4.03 | -5.37 | -5.92 | -1.74 | ||||
Return On Equity % | 2.18 | -2.22 | -5.16 | -8.13 | -1.39 | ||||
Return on Common Equity | 2.22 | -2.23 | -5.23 | -7.9 | -1.34 | ||||
Margin Analysis | |||||||||
Gross Profit Margin % | 68.02 | 57.73 | 36.43 | 44.28 | 54.64 | ||||
SG&A Margin | 69.57 | 64.18 | 90.11 | 82.01 | 48.44 | ||||
EBITDA Margin % | -5.23 | -36.78 | -73.53 | -66.43 | -8.03 | ||||
EBITA Margin % | -20.56 | -48 | -92.45 | -84.1 | -16.85 | ||||
EBIT Margin % | -36.09 | -60.43 | -107.69 | -97.5 | -26.18 | ||||
Income From Continuing Operations Margin % | 21.71 | -20.73 | -63.53 | -82.3 | -13.01 | ||||
Net Income Margin % | 21.98 | -20.73 | -63.98 | -79.38 | -12.57 | ||||
Net Avail. For Common Margin % | 21.98 | -20.73 | -63.98 | -79.38 | -12.57 | ||||
Normalized Net Income Margin | -15.25 | -31.25 | -61.95 | -49.3 | -13.49 | ||||
Levered Free Cash Flow Margin | -15.49 | -39.4 | -16.21 | -9.92 | -45.6 | ||||
Unlevered Free Cash Flow Margin | -15.49 | -39.35 | -15.89 | -9.65 | -45.57 | ||||
Asset Turnover | |||||||||
Asset Turnover | 0.08 | 0.09 | 0.07 | 0.08 | 0.09 | ||||
Fixed Assets Turnover | 0.94 | 1.01 | 0.59 | 0.71 | 1.13 | ||||
Receivables Turnover (Average Receivables) | 0.49 | 0.66 | 0.56 | 0.88 | 1.56 | ||||
Inventory Turnover (Average Inventory) | 0.45 | 0.62 | 0.68 | 0.68 | 0.66 | ||||
Short Term Liquidity | |||||||||
Current Ratio | 14.5 | 8.09 | 7.62 | 7.74 | 14.34 | ||||
Quick Ratio | 13.25 | 7.18 | 6.75 | 6.7 | 13.19 | ||||
Operating Cash Flow to Current Liabilities | 0.26 | -0.37 | 0.41 | -0.02 | 0.15 | ||||
Days Sales Outstanding (Average Receivables) | 744.52 | 551.24 | 656.43 | 412.54 | 233.88 | ||||
Days Outstanding Inventory (Average Inventory) | 809.64 | 589.5 | 534.84 | 535.19 | 558.63 | ||||
Average Days Payable Outstanding | 121.69 | 139.45 | 192.49 | 166.1 | 183.86 | ||||
Cash Conversion Cycle (Average Days) | 1.43T | 1T | 998.79 | 781.63 | 608.65 | ||||
Long Term Solvency | |||||||||
Total Debt/Equity | - | 0.23 | 3.21 | 0.17 | 0.24 | ||||
Total Debt / Total Capital | - | 0.23 | 3.11 | 0.17 | 0.24 | ||||
LT Debt/Equity | - | 0.17 | 0.09 | 0.08 | 0.18 | ||||
Long-Term Debt / Total Capital | - | 0.17 | 0.09 | 0.08 | 0.18 | ||||
Total Liabilities / Total Assets | 12.79 | 15.34 | 15.3 | 15.1 | 9.02 | ||||
EBIT / Interest Expense | - | -735.61 | -206.47 | -229.33 | -476.49 | ||||
EBITDA / Interest Expense | - | -440.14 | -139.76 | -154.36 | -132.67 | ||||
(EBITDA - Capex) / Interest Expense | - | -1.04T | -235.73 | -207.62 | -751.17 | ||||
Total Debt / EBITDA | - | -0.06 | -0.54 | -0.02 | -0.43 | ||||
Net Debt / EBITDA | 158.07 | 14.43 | 9.9 | 9.12 | 142.41 | ||||
Total Debt / (EBITDA - Capex) | - | -0.03 | -0.32 | -0.02 | -0.08 | ||||
Net Debt / (EBITDA - Capex) | 19.67 | 6.09 | 5.87 | 6.78 | 25.15 | ||||
Growth Over Prior Year | |||||||||
Total Revenues, 1 Yr. Growth % | -47.98 | 33.55 | -24.8 | 15.87 | 62.3 | ||||
Gross Profit, 1 Yr. Growth % | -48.1 | 13.34 | -52.33 | 36.58 | 124.79 | ||||
EBITDA, 1 Yr. Growth % | -152.44 | 1.35T | 57.41 | 9.2 | -79.17 | ||||
EBITA, 1 Yr. Growth % | 224.72 | 242.42 | 50.01 | 8.99 | -65.91 | ||||
EBIT, 1 Yr. Growth % | 62.03 | 123.62 | 34.01 | 4.91 | -56.44 | ||||
Earnings From Cont. Operations, 1 Yr. Growth % | -40.57 | -227.48 | 130.49 | 50.15 | -74.34 | ||||
Net Income, 1 Yr. Growth % | -40.19 | -225.93 | 132.12 | 43.78 | -74.3 | ||||
Normalized Net Income, 1 Yr. Growth % | 103.47 | 173.72 | 49.05 | -7.46 | -55.6 | ||||
Diluted EPS Before Extra, 1 Yr. Growth % | -47.56 | -206.98 | 132.61 | 43.93 | -74.03 | ||||
Accounts Receivable, 1 Yr. Growth % | -6.44 | 7.66 | -32.76 | -19.58 | 6.4 | ||||
Inventory, 1 Yr. Growth % | 46.14 | 17.06 | -9.76 | 14.25 | 57.92 | ||||
Net Property, Plant and Equip., 1 Yr. Growth % | 3.64 | 44.22 | 16.94 | -20.29 | 28.95 | ||||
Total Assets, 1 Yr. Growth % | 54.51 | 2.66 | -1.7 | -8.27 | 100.23 | ||||
Tangible Book Value, 1 Yr. Growth % | 78.67 | -0.3 | -0.81 | -11.98 | 130.31 | ||||
Common Equity, 1 Yr. Growth % | 69.54 | -0.34 | -2 | -7.82 | 115.33 | ||||
Cash From Operations, 1 Yr. Growth % | -84.21 | -337.03 | -215.67 | -105.46 | -907.77 | ||||
Capital Expenditures, 1 Yr. Growth % | -14.28 | 79.75 | -23.95 | -47.58 | 143.55 | ||||
Levered Free Cash Flow, 1 Yr. Growth % | -125.8 | 239.67 | -72.66 | -49.01 | 772.63 | ||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -125.8 | 239.23 | -73.18 | -49.65 | 800.18 | ||||
Compound Annual Growth Rate Over Two Years | |||||||||
Total Revenues, 2 Yr. CAGR % | -28.81 | -16.65 | 0.22 | -6.65 | 37.14 | ||||
Gross Profit, 2 Yr. CAGR % | -31.9 | -23.3 | -26.65 | -18.06 | 65.38 | ||||
EBITDA, 2 Yr. CAGR % | -58.47 | 122 | 366.93 | 28.37 | -53.72 | ||||
EBITA, 2 Yr. CAGR % | -6.53 | 218.18 | 122.7 | 25.74 | -40.47 | ||||
EBIT, 2 Yr. CAGR % | 85.17 | 90.35 | 73.11 | 18.57 | -32.39 | ||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -36.35 | -12.96 | 71.42 | 86.02 | -37.93 | ||||
Net Income, 2 Yr. CAGR % | -36.22 | -13.21 | 70.97 | 82.67 | -39.22 | ||||
Normalized Net Income, 2 Yr. CAGR % | -4.02 | 135.99 | 101.98 | 17.23 | -35.89 | ||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -40.39 | -25.1 | 57.75 | 82.97 | -38.86 | ||||
Accounts Receivable, 2 Yr. CAGR % | -12.06 | 0.36 | -14.91 | -26.46 | -7.5 | ||||
Inventory, 2 Yr. CAGR % | -9.24 | 30.8 | 2.78 | 1.54 | 34.32 | ||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 2.26 | 22.26 | 29.87 | -3.45 | 1.38 | ||||
Total Assets, 2 Yr. CAGR % | 24.54 | 25.95 | 0.46 | -5.03 | 35.53 | ||||
Tangible Book Value, 2 Yr. CAGR % | 42.09 | 33.47 | -0.56 | -6.56 | 42.38 | ||||
Common Equity, 2 Yr. CAGR % | 35.96 | 29.99 | -1.17 | -4.95 | 40.89 | ||||
Cash From Operations, 2 Yr. CAGR % | 163.82 | -38.82 | 65.58 | -74.87 | -33.6 | ||||
Capital Expenditures, 2 Yr. CAGR % | -10.5 | 24.13 | 16.92 | -36.86 | 12.99 | ||||
Levered Free Cash Flow, 2 Yr. CAGR % | -49.84 | -6.39 | 2.52 | -55.98 | 95.05 | ||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -49.84 | -6.45 | 1.49 | -56.55 | 96.4 | ||||
Compound Annual Growth Rate Over Three Years | |||||||||
Total Revenues, 3 Yr. CAGR % | -22.09 | -12.2 | -19.46 | 5.18 | 12.25 | ||||
Gross Profit, 3 Yr. CAGR % | -22.14 | -19.29 | -34.64 | -8.84 | 10.37 | ||||
EBITDA, 3 Yr. CAGR % | -44.62 | 17.47 | 94.95 | 183.66 | -31.37 | ||||
EBITA, 3 Yr. CAGR % | -7.33 | 39.66 | 144.76 | 73.55 | -19.89 | ||||
EBIT, 3 Yr. CAGR % | 37.96 | 97.19 | 69.34 | 46.5 | -15.07 | ||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -26.82 | -19.77 | 20.42 | 64 | -3.88 | ||||
Net Income, 3 Yr. CAGR % | -26.52 | -19.98 | 20.47 | 61.37 | -5 | ||||
Normalized Net Income, 3 Yr. CAGR % | -11.09 | 36.11 | 102.48 | 55.53 | -15.17 | ||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -29.74 | -27.56 | 9.28 | 53 | -4.55 | ||||
Accounts Receivable, 3 Yr. CAGR % | -2.08 | -5.92 | -12.18 | -16.5 | -16.83 | ||||
Inventory, 3 Yr. CAGR % | 3.31 | -1.21 | 15.57 | 6.47 | 17.64 | ||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 9.69 | 14.68 | 20.46 | 10.37 | 6.32 | ||||
Total Assets, 3 Yr. CAGR % | 18.12 | 16.77 | 15.96 | -2.53 | 21.78 | ||||
Tangible Book Value, 3 Yr. CAGR % | 28.27 | 26.26 | 20.89 | -4.52 | 26.22 | ||||
Common Equity, 3 Yr. CAGR % | 26.2 | 22.59 | 18.31 | -3.44 | 24.83 | ||||
Cash From Operations, 3 Yr. CAGR % | 17.16 | 154.57 | -24.35 | -46.91 | -20.1 | ||||
Capital Expenditures, 3 Yr. CAGR % | -18.1 | 12.92 | 5.42 | -10.51 | -0.98 | ||||
Levered Free Cash Flow, 3 Yr. CAGR % | -50.43 | -5.1 | -35.27 | -9.34 | 13.08 | ||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -50.43 | -5.15 | -35.71 | -10.16 | 13.1 | ||||
Compound Annual Growth Rate Over Five Years | |||||||||
Total Revenues, 5 Yr. CAGR % | - | -4.64 | -13.83 | -10.02 | -0.35 | ||||
Gross Profit, 5 Yr. CAGR % | - | -7.57 | -23.98 | -18.87 | -4.67 | ||||
EBITDA, 5 Yr. CAGR % | - | 16.04 | 19.13 | 20.6 | 8.76 | ||||
EBITA, 5 Yr. CAGR % | - | 27.63 | 29.16 | 32.98 | 38.12 | ||||
EBIT, 5 Yr. CAGR % | - | 33.65 | 51.07 | 60.89 | 17.29 | ||||
Earnings From Cont. Operations, 5 Yr. CAGR % | - | -8.77 | 2.86 | 12.31 | -7.62 | ||||
Net Income, 5 Yr. CAGR % | - | -8.77 | 3.01 | 11.32 | -8.37 | ||||
Normalized Net Income, 5 Yr. CAGR % | - | 15.12 | 23.45 | 28.22 | 27.73 | ||||
Diluted EPS Before Extra, 5 Yr. CAGR % | - | -14.21 | -2.91 | 4.94 | -13.37 | ||||
Accounts Receivable, 5 Yr. CAGR % | - | 5.98 | -7.43 | -14.75 | -10.34 | ||||
Inventory, 5 Yr. CAGR % | - | 17.3 | 3.1 | -0.12 | 22.74 | ||||
Net Property, Plant and Equip., 5 Yr. CAGR % | - | 22.48 | 17.36 | 7.05 | 12.43 | ||||
Total Assets, 5 Yr. CAGR % | - | 13.24 | 10.71 | 7.51 | 23.43 | ||||
Tangible Book Value, 5 Yr. CAGR % | - | 19.08 | 15.85 | 11.94 | 29.07 | ||||
Common Equity, 5 Yr. CAGR % | - | 17.07 | 14.44 | 10.73 | 26.87 | ||||
Cash From Operations, 5 Yr. CAGR % | - | 7.1 | 34.54 | 0.82 | -28.19 | ||||
Capital Expenditures, 5 Yr. CAGR % | - | 9.5 | -5.57 | -10.51 | 8.39 | ||||
Levered Free Cash Flow, 5 Yr. CAGR % | - | - | -33.71 | -28.46 | 7.48 | ||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | - | - | -33.98 | -28.84 | 7.46 |
- Stock Market
- Equities
- 688027 Stock
- Financials QuantumCTek Co., Ltd.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















